Good day, ladies and gentlemen, and welcome to the Dynavax Technologies fourth quarter and full year 2024 financial results ...
Dynavax Technologies Corporation ( NASDAQ: DVAX) Q4 2024 Earnings Conference Call February 20, 2025 4:30 PM ET Paul Cox - Vice President, Investor Relations & Corporate Communications Ryan Spencer - ...
Researchers say if their results are confirmed through further study they are optimistic the approach could be used to treat chronic infections for the first time.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback